ORGANIGRAM GLOBAL INC (OGI) Stock News
NASDAQ:OGI - Nasdaq - CA68617J1003 - Common Stock - Currency: USD
OGI Latest News, Press Relases and Analysis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025
Organigram Global Announces CEO Succession Plan
Mentions: OGI.CA
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OrganiGram (OGI) delivered earnings and revenue surprises of -66.67% and 8.09%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: TLSI
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
The analyst behind the change is now bullish on Teva's future. A positive change in recommendation from a well-known bank was the fuel propelling Teva Pharmaceutical Industries's (NYSE: TEVA) well higher on Monday. The company, known for being a top producer of generic drugs, saw its share price swell almost 6% as a result.
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) delivered earnings and revenue surprises of -333.33% and 29.59%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: TLSI
Organigram Reports Record Second Quarter Fiscal 2025 Results
Mentions: OGI.CA
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of 66.67% and 4.25%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: INFU
Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California
Mentions: OGI.CA
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards
Mentions: OGI.CA
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025
Mentions: OGI.CA
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 46.82% and 0.05%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: BIO
Organigram Global Congratulates Mark Carney on Election Win
Mentions: OGI.CA
Organigram Global’s Products Recognized at the CNB Awards
Mentions: OGI.CA
Organigram Global Shares Recording of its OG Investor Session
Mentions: OGI.CA
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future
Mentions: OGI.CA
Levi Strauss maintains annual forecast, shares surge more than 7%
(Reuters) -Levi Strauss maintained on Monday its annual forecast for sales and profit, excluding the impact of tariffs, and posted quarterly profit ahead of Wall Street targets, sending its shares up more than 7% in after hours trade. Sweeping tariffs by President Donald Trump have sparked concerns over a global downturn and sharp price hikes for items such as clothing and footwear. "While we recognize that we are operating in an uncertain environment, our global footprint, strong margin structure, and agile supply chain position us to navigate the balance of the year and beyond," President and Chief Executive Michelle Gass said in a statement on Monday.